SCHEMBL6223085

SCHEMBL6223085

COc1ccc(-c2ccc(OC(=O)Cl)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.54
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
BACE1 P56817 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
TP53 P04637 1/20 0.48
MAPK1 P28482 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
CA1 P00915 4/20 0.47
CA2 P00918 4/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC2 Q92769 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219040 0.94 CES2 (0.54) NPC1RAB9ASMN1; SMN2MAPK1CES2
SCHEMBL6565732 0.89 HSD17B10 (0.47) NPC1RAB9ASMN1; SMN2LMNACYP1A2
SCHEMBL8065698 0.83 ESR2 (0.58) ESR2NPC1RAB9ABACE1SMN1; SMN2
SCHEMBL6924446 0.82 RAB9A (0.46) RAB9ASMN1; SMN2LMNAALDH1A1GAA
SCHEMBL6223461 0.81 ESR2 (0.56) ESR2NPC1RAB9ABACE1SMN1; SMN2
SCHEMBL5665614 0.81 ELANE (0.44) SMN1; SMN2CYP1A2CYP2C19HPGDHTT
SCHEMBL1347723 0.81 KMT2A (0.53) NPC1RAB9ASMN1; SMN2CA1CA2
SCHEMBL2608606 0.81 HSD17B10 (0.66) ESR2NPC1RAB9ABACE1SMN1; SMN2
SCHEMBL14700512 0.81 HSD17B10 (0.66) ESR2NPC1RAB9ABACE1SMN1; SMN2
SCHEMBL6667738 0.79 CES2 (0.59) ESR2NPC1RAB9ASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534689-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-06-01 EP disclosed
WO-2004024702-A1 NOVEL CARBOXAMIDE COMPOUNDS HAVING AN MCH-ANTAGONISTIC EFFECT, MEDICAMENTS CONTAINING SAID COMPOUNDS, AND METHODS FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-03-25 WO disclosed